Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2006-03-21
2006-03-21
Helms, Larry R. (Department: 1642)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S387100, C424S130100, C424S156100
Reexamination Certificate
active
07015312
ABSTRACT:
The present invention discloses that the normal melanogenic gene, gp75 gene, encodes a gene product, a 24 amino acid peptide of ORF3, which is processed to an antigenic cancer peptide recognized by T lymphocytes. The cancer peptide of the invention derived from ORF3 is recognized by cancer antigen specific T lymphocytes as a tumor rejection antigen. The products of this gene are promising candidates for immunotherapeutic strategies for the treatment and diagnosis of patients with cancer.
REFERENCES:
patent: 5874560 (1999-02-01), Kawakami et al.
patent: WO 91/14775 (1991-10-01), None
patent: WO 94/03205 (1994-02-01), None
patent: WO 95/23814 (1995-09-01), None
Lederman et al., Molecular Immunology 28:1171-81, 1991.
Smilek et al PNAS 88:9633-37, 1991.
Lin et al., Biochemistry 14:1959, 1975.
Burgess et al., The Journal of Cell Biology 111:2129-38, 1990.
Schwartz et al., PNAS 84:6408-11, 1987.
Lazar et al., Molecular and Cellular Biology 8:1247-1252, 1988.
Kawakami, Y. et al, Identification of the Immunodominant Peptides of the MART-1 Human Melanoma Antigen Recognized by the Majority of HLA-A2-restricted Tumor Infiltrating Lymphocytes,The Journal of Experimental Medicine, vol. 180, pp. 347-352, Jul. 1994.
Yokoyama et al, Molecular cloning and functional analysis of a cDNA coding for human DOPAchrome tautomerase/tyrosinase-related protein-2,Biochimica et Biophysica Acta, 1217 (1994) 317-321.
Vijayasaradhi et al, The Melanoma Antigen gp75 is The Human Homologue Of The Mouse b (Brown) Locus Gene Product,J. Exp. Med., vol. 171, Apr. 1990, pp. 1375-1380.
Cohen et al, Nucleotide sequence of the cDNA encoding human tyrosinase-related protein,Nucleic Acids Research, vol. 18, No. 9, May 11, 1990, pp. 2807-2808.
Bloom et al, Identification of Tyrosinase-related Protein 2 as a Tumor Rejection Antigen for the B16 Melanoma,Journal of Experimental Medicine, vol. 185, No. 3, pp. 453-459, Feb. 3, 1997.
Wang et al, Identification of TRP-2 as a Human Tumor Antigen Recognized by Cytotoxic T Lymphocytes,The Journal of Experimental Medicine, vol. 184, pp. 2207-2216, Dec. 1996.
Orlow et al, Changes in expression of putative antigens encoded by pigment genes in mouse melanomas at different stages of malignant progression,Proc. Natl. Acad. Sci. USA, vol. 92, pp. 10152-10156, Oct. 1995.
Hara et al, Implicating a Role for Immune Recognition of Self in Tumor Rejection: Passive Immunization against theBrownLocus Protein,J. Exp. Med., vol. 182, Nov. 1995, pp. 1609-1614.
Quelle et al, Alternative Reading Frames of the INK4a Tumor Suppressor Gene Encode Two Unrelated Proteins Capable of Inducing Cell Cycle Arrest,Cell, vol. 83, Dec. 15, 1995, pp. 993-1000.
Malarkannan et al, A Rare Cryptic Translation Product Is Presented by KbMajor Histocompatibility Complex Class I Molecule to Alloreactive T Cells,J. Exp. Med., vol. 182, Dec. 1995, pp. 1739-1750.
Wang et al, Identification of a Gene Encoding a Melanoma Tumor Antigen Recognized by HLA-A31-restricted Tomor-infiltrating Lymphocytes,The Journal of Experimental Medicine, vol. 181, Feb. 1995, pp. 799-804.
Wang et al, Human tomor antigens recognized by T lymphocytes: Implications for cancer therapy,J. Leukocytes Biol., vol. 60, pp. 296-309, Sep. 1990.
Uenaka et al, Identification of a Unique Antigen Peptide pRL1 on BALB/c RL01 Leukemia Recognized by Cytotoxic T Lymphocytes and Its Relation to the Akt Oncogene,J. Exp. Med., vol. 180, pp. 1599-1607, Nov. 1994.
Salgaller et al, Immunization against Epitopes in the Human Melanoma Antigen gp100 following Patient Immunization with Synthetic Peptides,Cancer Research, vol. 56:4749-4757, Oct. 1996.
Wang et al, “Utilization of an alternative open reading frame of a normal gene in generating a novel human cancer antigen”,The Journal of Experimental Medicine, vol. 183, No. 3, Mar. 1, 1996, pp. 1131-1140.
Bennett et al, Phenotypic rescue of mutant brown melanocytes by a retrovirus carrying a wild-type tyrosinase-related protein gene, Developement, vol. 110:471-475, 1990.
Murty et al. Assignment of the human TYRP (brown) locus to chromosome region 9p23 by nonradioactive in situ hybridzation, Genomics 13:227-229, 1992.
Cohen et al.,Nucleic Acids Res., 18(9), 2807-2808 (1990).
Miyoshi et al.,Hum. Mol. Genet., 1(4), 229-233 (1992).
Orlow et al.,Proc. Nat. Acad. USA, 92, 10152-10156 (1995).
Townsend et al.,Nature, 371, 662, (1994).
Wang et al.,J. Exp. Med., 181(2), 799-804 (1995).
Wang et al.,J. Exp. Med., 183(3), 1131-1140 (1996).
Wang et al.,J. Leukocyte Biol., 60(3), 296-309 (1996).
Rosenberg Steven A.
Wang Rong-Fu
Helms Larry R.
Leydig , Voit & Mayer, Ltd.
The United States of America as represented by the Department of
LandOfFree
Antibodies to the protein product encoded by ORF3 of the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibodies to the protein product encoded by ORF3 of the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies to the protein product encoded by ORF3 of the... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3529083